Pulmonary hypertension (PH) is a complex and progressive condition characterized by elevated blood pressure in the pulmonary arteries. Despite significant advancements in medical science, it remains a challenging condition to manage due to its diverse etiology and nonspecific clinical presentation.
PH is primarily a disease of the small pulmonary arteries. The pathophysiological hallmarks include vasoconstriction, vascular remodeling, and in situ thrombosis. These changes lead to a progressive increase in pulmonary vascular resistance, culminating in right heart failure if left untreated.
PH often presents with nonspecific symptoms such as dyspnea, fatigue, and syncope. The diagnosis is confirmed by right heart catheterization, demonstrating a mean pulmonary artery pressure of ≥25 mmHg at rest. Non-invasive tests like echocardiography and computed tomography can provide supportive evidence.
Although PH is incurable, treatment aims to improve symptoms, slow disease progression, and enhance quality of life. Therapeutic strategies include vasodilators, endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, and soluble guanylate cyclase stimulators. In severe cases, lung transplantation may be considered.
Emerging research is exploring novel therapeutic targets, such as the prostacyclin pathway and immune modulation. Personalized medicine, based on genetic and molecular profiling of patients, also holds promise for improving outcomes in PH.
PH is a complex condition requiring a comprehensive understanding of its pathophysiology, clinical presentation, and treatment approaches. As we continue to unravel the intricacies of this disease, it is crucial for medical professionals to stay updated on the latest research and therapeutic developments. This will enable us to provide the best possible care for our patients and improve their quality of life.
1.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
2.
FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer
3.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
4.
AI-based liquid biopsy shows promise for detecting brain cancer
5.
The Kansas Cancer Center awarded two Indian American doctors professorships.
1.
Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers
2.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
3.
Examining Serum Osmolality: What It Is And How To Test For It
4.
Evolutionary Bottlenecks in Tumor Progression
5.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Thromboprophylaxis In Medical Settings
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation